Mary Agnes Templeton

Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis

Matthew N. Sirott, Dean F. Bajorin, George Y. Wong et al. · Cancer · 1993 · 227 citations · Full text

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.

Saroj Vadhan‐Raj, Carlos Cordon‐Cardo, E A Carswell et al. · Journal of Clinical Oncology · 1988 · 152 citations

Immunotoxicology, Immunology, Immunoediting +22

Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.

Dean F. Bajorin, Paul B. Chapman, G Wong et al. · PubMed · 1990 · 88 citations

Immunology, Immunoediting, Immunologic Mechanism +20

Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer.

Ann A. Jakubowski, E. S. Casper, Janice Gabrilove et al. · Journal of Clinical Oncology · 1989 · 77 citations

Surgical Oncology, Pathology, Pharmacotherapy +20

Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma

Dean F. Bajorin, Paul B. Chapman, George Y. Wong et al. · Melanoma Research · 1992 · 47 citations